Phase II randomized trial of capecitabine 1 radiation therapy with/without bevacizumab as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: Final results of 3 and 5-year disease free survival, distant relapse free survival and overall survival
Por:
Gravalos, C, Capdevila, J, Layos, L, Pericay, C, Martinez-Villacampa, M, Lopez, CL, Losa, F, Safont, MJ, Gomez-Espana, A, Alonso, V, Escudero, P, Gallego, J, Garcia-Paredes, B, Palacios, A, Biondo, S, Salazar, R and Aguilar, EA
Publicada:
1 sep 2017
Resumen:
Filiaciones:
Gravalos, C:
Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain
Capdevila, J:
Vall dHebron Univ Hosp, Gastrointestinal & Endocrine Tumor Unit, Barcelona, Spain
:
Hosp Badalona Germans Trias & Pujol, Inst Catalan Oncol, Med Oncol, Badalona, Spain
Pericay, C:
Corp Sanitaria Parc Tauli, Med Oncol, Sabadell, Spain
Martinez-Villacampa, M:
Hosp Duran & Reynals, Inst Catalan Oncol, Barcelona, Spain
Lopez, CL:
Hosp Univ Marques de Valdecilla, Med Oncol, Santander, Spain
Losa, F:
Hosp St Joan Despi Moises Broggi, Med Oncol, Barcelona, Spain
Safont, MJ:
Hosp Gen Univ Valencia, Med Oncol, Valencia, Spain
Gomez-Espana, A:
Univ Cordoba, CIBERONC Inst Salud Carlos 3, Reina Sofia Hosp, Med Oncol,IMIBIC, Cordoba, Spain
Alonso, V:
Hosp Miguel Servet, Med Oncol, Zaragoza, Spain
Escudero, P:
Hosp Clin Univ Lozano Blesa, Med Oncol, Zaragoza, Spain
Gallego, J:
Hosp Gen Univ Elche, Med Oncol, Alicante, Spain
Garcia-Paredes, B:
Hosp Univ Clin San Carlos, CIBERONC Inst Salud Carlos 3, Med Oncol, Madrid, Spain
Palacios, A:
Hosp Reina Sofia, Radiat Oncol, Cordoba, Spain
Biondo, S:
Hosp Univ Bellvitge, Gen & Digest Surg, Barcelona, Spain
Salazar, R:
Hosp Duran & Reynals, Inst Catala Oncol, Med Oncol, Barcelona, Spain
Aguilar, EA:
Univ Hosp Reina Sofia, CIBERONC Inst Salud Carlos 3, Med Oncol, Cordoba, Spain
|